Speech-Language Pathologists in Huntington Woods, MI Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Marci Frank Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 26410 Huntington Rd, Huntington Woods, MI 48070 Phone: 248-219-7920

Ms. Nicole Arbutus Stewart, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13116 Borgman Ave, Huntington Woods, MI 48070 Phone: 248-752-8467

Mrs. Stacey Anne Shulman, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26385 Humber St, Huntington Woods, MI 48070 Phone: 248-770-4042

Lori Place Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13343 Lasalle Blvd, Huntington Woods, MI 48070 Phone: 734-377-7115

Stewart Slp, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13116 Borgman Ave, Huntington Woods, MI 48070 Phone: 248-752-8467

News Archive

LGBT seniors face higher rates of disability, physical and mental distress

Aging and health issues facing lesbian, gay, bisexual and transgender baby boomers have been largely ignored by services, policies and research. These seniors face higher rates of disability, physical and mental distress and a lack of access to services, according to the first study on aging and health in these communities.

Innate differences in immunity can be detected at birth

Innate differences in immunity can be detected at birth, according to new research at Washington University School of Medicine in St. Louis. And babies with a better innate response to viruses have fewer respiratory illnesses in the first year of life.

EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.

Retina Implant announces opening of new manufacturing plant in Tübingen-Reutlingen

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the opening of a new manufacturing plant to meet anticipated demand for their implants. The company's second human clinical trial will be expanding outside of Germany in early 2011 to European countries including the U.K. and Italy and discussions are underway for potential clinical trials in the United States and Asia. Also looking ahead, the new facility meets manufacturing capabilities required for CE mark approval.

Read more Medical News

› Verified 5 days ago